FF 100 μg (N=1010) | FF/VI 100/25 μg (N=1009) | |
---|---|---|
Adjusted % probability of a severe asthma exacerbation by 52 weeks* | 15.9 (13.5 to 18.2) | 12.8 (10.7 to 14.9) |
FF/VI 100/25 μg vs FF 100 μg | ||
HR† | 0.795 (0.642 to 0.985) | |
p Value† | 0.036 |
Values are mean (95% CI) unless otherwise stated.
*Cox proportional hazards model estimate at mean baseline FEV_{1}, age and proportional coefficients for sex and region.
†Adjusted for the interim analysis.
FF, fluticasone furoate; HR, hazard ratio; VI, vilanterol.